2017 Senate Bill 492

Impose oral chemotherapy insurance mandate

Introduced in the Senate

June 22, 2017

Introduced by Sen. Goeff Hansen (R-34)

To impose a new coverage mandate that would require insurance companies to include coverage for orally administered chemotherapy in all their health insurance policies that provide for cancer chemotherapy treatments, without requiring any dollar limit, deductible or co-pay for these that does not apply to other treatments. Also, to prohibit an insurer from requiring a copayment greater than $100 for a 30 day supply of the pills.

Referred to the Committee on Insurance

Oct. 12, 2017

Reported without amendment

With the recommendation that the substitute (S-1) be adopted and that the bill then pass.

Oct. 18, 2017

Passed in the Senate 36 to 1 (details)

Received in the House

Oct. 18, 2017

Referred to the Committee on Insurance

June 7, 2018

Reported without amendment

With the recommendation that the bill be referred to the Committee on Health Policy.

Referred to the Committee on Health Policy